Oncology cell lines preclinicalVxP Pharma offers over 100 well-characterized Tumor Cell Line Xenograft models. Our team has extensive experience working with some of the world’s largest pharma companies, as well as many small and virtual companies. We offer custom development of multiple models to help you achieve your goals.

Some of our Xenograft Models are as follows:

Cancer Type Human Cancer Cell Lines
Head and Neck FaDu, Detroit 562, CAL-27
Oral Epithelial Carcinoma KB
Lung Cancer DMS114, NCI-H69, NCl-H146, NCl-H209, NCI-H446, NCI-H526, NCI-H1688, 95-D, A549, Calu-1, Calu-3, Calu-6, HCC827, NCI-H226, NCI-H292, NCI-H358, NCI-H441, NCI-H460, NCI-H520, NCI-H522, NCI-H1299, NCI-H1437, NCI-H1650, NCI-H1975, NCI-H1993, NCI-H2009, NCI-H2122, NCI-H2126, NCI-H2228, PC-10, QG-56, A427, H23, H1568, H2110
Breast Cancer SUM159, MDA-MB-231, MDA-MB-468, Bcap-37, 2LMP, ZR-75-1, ZR-75-30, HCC70, HCC1954, MDA-MB-361, MCF-7, BT474
Gastric Cancer MKN-45, NCI-N87, BGC-823, HGC-27, MKN-28, NUGC-3, SCH, SGC-7901, SNU-5, SNU-16, MGC-803
Pancreatic Cancer AsPC-1, BxPC-3, Capan-1, Capan-2, CFPAC-1, HPAF-II,  MIAPaCa-2,  PANC-1, PANC-10.05
Renal Cancer ACHN, OS-RC-2, 786-O, A498
Hepatocellular Carcinoma Bel-7402, Hep-3B, Huh-7, PLC/PRF/5, QGY-7703, SK-HEP-1, SMMC-7721, HepG-2, JHH7
Glioblastoma U87-MG
Colon and Cecum Cancer COLO 201, COLO 205, COLO 320 DM, CW-2, DLD-1, HCT-8, HCT-15, HCT-116, HT-29, LoVo, LS1034, LS174T, LS411N, NCI-H716, RKO , SW48, SW620, WiDr, SW948, DiFi
Prostate Cancer DU145,PC-3, LNCap, CL-1,
Urinary Bladder HT-1197, HT-1376, RT4, SCaBER, SW780, T24
Ovarian Cancer ES-2, HO-8910PM, PA-1, SK-OV-3, OVCAR-3
Endometrium/Hysterocarcinoma AN3 CA, HEC-1-A, ME-180, MFE-280
Cervical cancer SiHa, Hela
Skin Cancer A431, Colo829
Melanoma A375, A2058, C32, HMCB, SK-MEL-30, MDA-MB-435s, WM-226-4
Osteosarcoma MG-63, SJSA-1
Fibrosarcoma HT-1080
Muscle, Striated SJCRH30
Myeloma KMS-11, KMS-26, RPMI-8226 ,MM.1S
Leukemia / Lymphoma U937, THP-1, MV-4-11, HEL, TF-1a, ML-2, HL-60,  K562, KARPAS-299, Daudi, RL, Mino, Raji, Ramos, ARH-77, KMS-12-BM, KG-1, JeKo-1, MAVER-1, CML-T1, MOLM-13, TMD-8, OCI-LY10, Nalm-6

Tumor Cell Line Xenograft models are excellent predictors of the cytotoxicity of cancer drugs, and are extensively used in efficacy studies. The benefits of xenograft models include overall simplicity, as well as easy access for tumor measurement.

VxP currently offers a wide range of Xenograft models derived from human cancer cell lines. Please contact us if you would like to learn more.